ResMed’s acquisition of MEDIFOX DAN is official
By HME News Staff
Updated 9:29 AM CST, Mon November 28, 2022
SAN DIEGO and HILDESHEIM, Germany – ResMed has completed its acquisition of MEDIFOX DAN for 958.6 million Euros. MEDIFOX DAN, which is headquartered in Hildesheim, Germany, and employs 700, now operates under its current brand within the ResMed SaaS business segment, which also includes Brightree and MatrixCare. “We’re excited to have closed this important expansion of our SaaS business and to officially welcome MEDIFOX DAN to our ResMed SaaS team and global ResMed family,” said ResMed CEO Mick Farrell. “MEDIFOX DAN is a German leader in software innovation, united with the rest of ResMed in its mission to improve tens of millions of people’s lives through technology. Today, its strong offerings and dedicated staff expand ResMed’s out-of-hospital SaaS business into new health sectors, and to build on our strong ResMed healthcare business in Germany, the world’s second largest health care market in per capita spending.” ResMed intends to retain MEDIFOX DAN’s employees, locations and business processes. The company will report into ResMed SaaS President Bobby Ghoshal.
- Read why ResMed calls MEDIFOX DAN the company’s ‘beachhead’ for global expansion in Europe.
- Read Bobby Ghoshal’s take on how technology can up the HME provider’s game.
Comments